Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- calcium acetate / magnesium carbonate
- erdafitinib
Interactions between your drugs
magnesium carbonate erdafitinib
Applies to: calcium acetate / magnesium carbonate, erdafitinib
Using erdafitinib together with magnesium carbonate may alter the levels of phosphate in the blood, which may affect the dose of erdafitinib. Your doctor will check your blood phosphate level between 14 and 21 days after starting treatment with erdafitinib and then monthly, and may change your dose if necessary. Talk to your doctor if you have any questions or concerns. Contact your doctor as soon as possible if you develop signs and symptoms of high phosphate levels in the blood (hyperphosphatemia) such as muscle cramps, convulsions, tingling or numbness around the mouth, and bone pain. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
calcium acetate erdafitinib
Applies to: calcium acetate / magnesium carbonate, erdafitinib
Using erdafitinib together with calcium acetate may alter the levels of phosphate in the blood, which may affect the dose of erdafitinib. Your doctor will check your blood phosphate level between 14 and 21 days after starting treatment with erdafitinib and then monthly, and may change your dose if necessary. Talk to your doctor if you have any questions or concerns. Contact your doctor as soon as possible if you develop signs and symptoms of high phosphate levels in the blood (hyperphosphatemia) such as muscle cramps, convulsions, tingling or numbness around the mouth, and bone pain. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
No alcohol/food interactions were found with the drugs in your list. However, this does not necessarily mean no food interactions exist. Always consult your healthcare provider.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Amphojel
Amphojel is used for duodenal ulcer, erosive esophagitis, gastrointestinal hemorrhage, GERD ...
Auryxia
Auryxia is used for hyperphosphatemia of renal failure, iron deficiency anemia
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Fosrenol
Fosrenol (lanthanum carbonate) reduces phosphate levels in patients with end stage renal disease ...
Renagel
Renagel (sevelamer) is used to reduce levels of phosphorus in people with kidney disease who are on ...
Renvela
Renvela (sevelamer) reduces blood levels of phosphorus in people with chronic kidney disease who ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.